COMMUNIQUÉS West-GlobeNewswire

Colibri Heart Valve to Present One-Year Patient Follow-Up Results from Clinical Feasibility Study of Second-Generation TAVI System at EuroPCR
14/05/2019
BROOMFIELD, CO , May 14, 2019 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC , a privately held emerging medical device company, today announced that results from the company’s international, single-arm, open-label early [...]
Y-mAbs Announces Development Update on Cancer Vaccine Program
14/05/2019
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, [...]
CURE Pharmaceutical (OTCQB:CURR) Closes Acquisition Of Privately-Held Chemistry Holdings Inc.
14/05/2019
Acquired Technology Expands Core CUREfilmTM Platform and Strengthens Balance Sheet OXNARD, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development [...]
Oxford Immunotec to Present at the UBS Global Healthcare Conference
14/05/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that Dr. Peter [...]
JSC “Grindeks” Group could reach 300 million euro turnover within five years
14/05/2019
According to the interview with Chairman of the Council of JSC “Grindeks” Kirovs Lipmans, published by National information agency LETA on 14 May 2019, JSC “Grindeks” confirms that in five years JSC “Grindeks” could [...]
Sienna Biopharmaceuticals Announces SNA-120 (0.05%) Biopsy Data Demonstrate Positive Impact on Key Inflammatory Cytokines, including IL-23 and IL-17, in Psoriasis
14/05/2019
-- Biopsy data support strong clinical effect observed in Phase 2 trials with SNA-120 -- Following Positive End-of-Phase 2 meeting with FDA, Sienna continues toward enrolling first patient in Phase 3 program in second [...]
Ventura Cannabis (VCAN) Executes LOI to Divest Corona Detox Center for $1.4M in Cash; VCAN to Retain 10-year Rights to Exclusively Supply All Cannabis Products for Opioid Treatment to Detox Center’s Patients
14/05/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, May 14, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
Turning Point Therapeutics Names Biotech Veteran Patrick Machado, J.D. to Its Board of Directors
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced the appointment of [...]
AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference
14/05/2019
NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “Axim”, or the “Company”), a world leader in cannabinoid research and development, today announced that the Company [...]
Cerner to Work With DrFirst to Connect to State Prescription Drug Monitoring Programs
14/05/2019
KANSAS CITY, Mo., May 14, 2019 (GLOBE NEWSWIRE) -- Cerner (Nasdaq: CERN), a global health platform and innovation company, and DrFirst, a leading provider of medication management and data solutions, are working [...]
Adamis Pharmaceuticals Announces Conditional Acceptance by FDA of Proprietary Name for Higher Dose Naloxone Product
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today conditional acceptance by the U.S. Food and Drug Administration (FDA) of the proposed brand name for the [...]
Predictive Biotech Signs Letter of Intent With IQVIA to Begin Clincial Trial for Osteoarthritis of the Knee
14/05/2019
Company shifts focus of human cell and tissue products to biopharmaceuticals SALT LAKE CITY, May 14, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for [...]
Shineco, Inc. Enters into Strategic Cooperation Agreement with Heilongjiang Provincial Science Research Institute of Healthy Food to Establish NewHemp Food Processing Laboratory
14/05/2019
BEIJING, May 14, 2019 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various [...]
Homology Medicines Announces FDA Fast Track Designation for HMI-102 Gene Therapy Development Candidate for Adults with PKU
14/05/2019
- Company Provides Details of pheNIX, the First Gene Therapy Trial for PKU, and Remains on Track to Report Initial Clinical Results from the Phase 1/2 Study in 2019 - BEDFORD, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- [...]
Driven Deliveries, Inc. Enters $530 Million Nevada Cannabis Market
14/05/2019
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- Driven Deliveries, Inc., (OTC: DRVD), the world’s first publicly traded cannabis delivery company, announced today that it has successfully launched operations in Nevada with [...]
Transactions in relation to share buyback program
14/05/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
CV Sciences’ PlusCBD Oil™ Used in First Study Examining Clinical Benefit of CBD for Patients with PTSD
14/05/2019
Study Finds CBD Associated with PTSD Symptom Reduction in Adults with PTSD LAS VEGAS, May 14, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent [...]
CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients
14/05/2019
Extending Medicare coverage of medication saves $73M BRISBANE, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and [...]
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q1 2019
14/05/2019
Enrollment in Second Cohort of PDA Combination Study Completed New Funding Totaling $0.8 Million Secured MINNEAPOLIS, May 14, 2019 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), a clinical stage biopharmaceutical [...]

Pages